title: Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders.
abstract: OBJECTIVE
  To assess the results of palmar and axillary hyperhidrosis treatment in males and females using low doses of oxybutynin.
  
  
  METHODS
  A retrospective analysis was conducted in 395 women and 170 men followed up in our service with complaint of palmar and axillary hyperhidrosis.
  
  
  RESULTS
  A total of 70% of patients in both groups presented partial or great improvement in the level of hyperhidrosis after treatment. The best results were obtained in the female group, in which 40% classified their improvement as "great". Approximately 70% of the patients in both groups improved their quality of life after medical therapy and 30% presented no change in condition.
  
  
  CONCLUSIONS
  Gender is not a factor that significantly interferes in oxybutynin treatment results. Quality of life indices and clinical improvement level were similar in men and women.
authors: Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
authors: Nelson
authors: N
authors: Wolosker
authors: Mariana
authors: M
authors: Krutman
authors: Taiz Pereira Donozo Almeida
authors: TP
authors: Campdell
authors: Paulo
authors: P
authors: Kauffman
authors: Jose Ribas Milanez de
authors: JR
authors: Campos
authors: Pedro
authors: P
authors: Puech-Leão
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001365:Axilla; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D005260:Female; D006225:Hand; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011788:Quality of Life; D012189:Retrospective Studies; D012737:Sex Factors; D016896:Treatment Outcome; D014987:Xerostomia / Q000139:chemically induced; D055815:Young Adult
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin